The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Davydovskaia1 M.V.

Boĭko1 A.N.

Podoprigora2 A.E.

Pronin2 I.N.

Kornienko2 V.N.

Gusev1 E.I.

The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with -interferon 1a (avonex)

Authors:

Davydovskaia1 M.V., Boĭko1 A.N., Podoprigora2 A.E., Pronin2 I.N., Kornienko2 V.N., Gusev1 E.I.

More about the authors

Views: 765

Downloaded: 5


To cite this article:

Davydovskaia1 MV, Boĭko1 AN, Podoprigora2 AE, Pronin2 IN, Kornienko2 VN, Gusev1 EI. The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with -interferon 1a (avonex). S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(7):36‑41. (In Russ.)

Recommended articles:
A case of COVID-associated ence­phalopathy in a patient with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):159-163
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Features of primary forms of headache in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73
Neurofilament light chain: a diagnostic pote­ntial for multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):115-119

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.